- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
Infant formulas are unique because they are the only source of nutrition for many infants during the first 4 to 6 months of life. They are critical to infant health since they must safely support growth and development during a period when the consequences on inadequate nutrition are most severe. Existing guidelines and regulations for evaluating the safety of conventional food ingredients (e.g., vitamins and minerals) added to infant formulas have worked well in the past; however they are not sufficient to address the diversity of potential new ingredients proposed by manufacturers to develop formulas that mimic the perceived and potential benefits of human milk. This book, prepared at the request of the Food and Drug Administration (FDA) and Health Canada, addresses the regulatory and research issues that are critical in assessing the safety of the addition of new ingredients to infants.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- COVER PAGE
- THE NATIONAL ACADEMIES
- COMMITTEE ON THE EVALUATION OF THE ADDITION OF INGREDIENTS NEW TO INFANT FORMULA
- FOOD AND NUTRITION BOARD
- Reviewers
- Preface
- Contents
- Executive Summary
- 1 Introduction and Background
- 2 Defining Safety for Infants
- 3 Comparing Infant Formulas with Human Milk
- 4 Strengthening the Current Processes to Evaluate New Ingredients for Infant Formulas
- 5 Testing Ingredients with Preclinical Studies
- 6 Going Beyond Current Clinical Studies
- 7 Selecting an In-Market Surveillance Plan
- A Acronyms and Glossary
- B Composition of Infant Formulas and Human Milk for Feeding Term Infants in the United States
- C Redbook Table of Contents
- D Applying the Recommended Approaches
- E Biographical Sketches of Committee Members